Who owns Liminatus Pharma, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of LIMN from SEC Form 13F filings across 14 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 14 institutions disclosed 945,955 shares of Liminatus Pharma, Inc. worth $69,133 — about 97.7% of shares outstanding; the largest disclosed holder is Cygnus Capital Advisors, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
14
13F holders
$69,133
value, 2026 filers
97.7%
of shares outstanding (945,955 sh)
4
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of LIMN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Cygnus Capital Advisors, LLC | 329,333 | $36 | 0.0% | 34% | -5.9% |
| 2 | XTX Topco LtdNEW | 221,839 | $24,491 | 0.0% | 22.9% | new |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 138,418 | $15,282 | 0.0% | 14.3% | +17.5% |
| 4 | CITADEL ADVISORS LLC | 56,089 | $6,192 | 0.0% | 5.8% | -91.7% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 50,440 | $5,548 | 0.0% | 5.2% | 0.0% |
| 6 | GOLDMAN SACHS GROUP INCNEW | 40,220 | $4,440 | 0.0% | 4.2% | new |
| 7 | StoneX Group Inc.NEW | 26,058 | $3,934 | 0.0% | 2.7% | new |
| 8 | VANGUARD FIDUCIARY TRUST CO | 22,984 | $2,528 | 0.0% | 2.4% | 0.0% |
| 9 | STATE STREET CORP | 19,000 | $2,098 | 0.0% | 2% | 0.0% |
| 10 | UBS Group AG | 16,730 | $1,840 | 0.0% | 1.7% | -69.3% |
| 11 | Vanguard Personalized Indexing Management, LLC | 13,148 | $1,452 | 0.0% | 1.4% | -62.1% |
| 12 | Tower Research Capital LLC (TRC) | 7,093 | $783 | 0.0% | 0.7% | -6.3% |
| 13 | BARCLAYS PLCNEW | 4,290 | $474 | 0.0% | 0.4% | new |
| 14 | BlackRock, Inc. | 313 | $35 | 0.0% | 0% | -97.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.